Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Head and Neck Neoplasms | 38 | 2024 | 2895 | 2.400 |
Why?
|
Paranasal Sinus Neoplasms | 13 | 2024 | 242 | 2.290 |
Why?
|
Free Tissue Flaps | 15 | 2024 | 331 | 1.850 |
Why?
|
Carcinoma, Squamous Cell | 32 | 2024 | 4026 | 1.840 |
Why?
|
Skull Base | 5 | 2017 | 292 | 1.630 |
Why?
|
Nose Neoplasms | 8 | 2023 | 249 | 1.340 |
Why?
|
Oropharyngeal Neoplasms | 10 | 2023 | 491 | 1.250 |
Why?
|
Surgical Flaps | 19 | 2021 | 1671 | 1.170 |
Why?
|
Deglutition Disorders | 3 | 2023 | 625 | 1.040 |
Why?
|
Laryngectomy | 7 | 2023 | 243 | 1.040 |
Why?
|
Mouth Neoplasms | 6 | 2023 | 596 | 1.030 |
Why?
|
Parotid Neoplasms | 5 | 2020 | 157 | 1.000 |
Why?
|
Tongue Neoplasms | 4 | 2023 | 183 | 0.950 |
Why?
|
Skull Base Neoplasms | 5 | 2017 | 270 | 0.860 |
Why?
|
Carcinoma, Adenoid Cystic | 9 | 2022 | 262 | 0.810 |
Why?
|
Papillomavirus Infections | 8 | 2023 | 1613 | 0.810 |
Why?
|
Esophageal Stenosis | 1 | 2023 | 196 | 0.790 |
Why?
|
Laryngeal Neoplasms | 6 | 2018 | 514 | 0.780 |
Why?
|
Esthesioneuroblastoma, Olfactory | 5 | 2023 | 58 | 0.760 |
Why?
|
Nasal Cavity | 6 | 2023 | 304 | 0.710 |
Why?
|
Hypopharyngeal Neoplasms | 4 | 2024 | 51 | 0.670 |
Why?
|
Speech Disorders | 2 | 2021 | 180 | 0.640 |
Why?
|
Temporal Bone | 3 | 2014 | 683 | 0.610 |
Why?
|
Glossectomy | 2 | 2023 | 60 | 0.560 |
Why?
|
Lymphatic Metastasis | 4 | 2022 | 2915 | 0.520 |
Why?
|
DNA Helicases | 1 | 2020 | 851 | 0.480 |
Why?
|
Maxillary Sinus Neoplasms | 1 | 2014 | 39 | 0.450 |
Why?
|
Rectus Abdominis | 1 | 2012 | 103 | 0.400 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 5 | 2021 | 324 | 0.400 |
Why?
|
Salivary Ducts | 1 | 2012 | 25 | 0.400 |
Why?
|
Skull Fractures | 1 | 2013 | 202 | 0.400 |
Why?
|
Inappropriate ADH Syndrome | 1 | 2012 | 61 | 0.390 |
Why?
|
Ear Neoplasms | 3 | 2014 | 118 | 0.380 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2020 | 3514 | 0.360 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2024 | 9280 | 0.350 |
Why?
|
Histones | 1 | 2020 | 2580 | 0.340 |
Why?
|
Human papillomavirus 11 | 1 | 2009 | 14 | 0.340 |
Why?
|
Respiratory Tract Neoplasms | 1 | 2009 | 56 | 0.330 |
Why?
|
Neoplasm Invasiveness | 9 | 2023 | 3595 | 0.330 |
Why?
|
Postoperative Complications | 16 | 2024 | 15631 | 0.330 |
Why?
|
Papilloma | 1 | 2009 | 140 | 0.310 |
Why?
|
Salvage Therapy | 5 | 2024 | 1264 | 0.310 |
Why?
|
Carcinoma | 4 | 2015 | 2330 | 0.300 |
Why?
|
Retrospective Studies | 46 | 2024 | 80636 | 0.300 |
Why?
|
Surgical Wound Infection | 5 | 2021 | 1527 | 0.290 |
Why?
|
Parotid Gland | 4 | 2023 | 175 | 0.280 |
Why?
|
Carrier Proteins | 1 | 2020 | 4936 | 0.280 |
Why?
|
Skull Neoplasms | 1 | 2007 | 173 | 0.280 |
Why?
|
Nasal Mucosa | 2 | 2021 | 416 | 0.270 |
Why?
|
Cell Proliferation | 3 | 2020 | 10445 | 0.260 |
Why?
|
Larynx, Artificial | 3 | 2011 | 69 | 0.260 |
Why?
|
Papillomaviridae | 4 | 2022 | 1119 | 0.260 |
Why?
|
Duodenal Neoplasms | 1 | 2006 | 114 | 0.250 |
Why?
|
Humans | 108 | 2024 | 761504 | 0.240 |
Why?
|
Laryngeal Diseases | 2 | 2020 | 243 | 0.240 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 3 | 2020 | 1092 | 0.230 |
Why?
|
Keratins | 1 | 2006 | 498 | 0.230 |
Why?
|
Disease-Free Survival | 9 | 2024 | 6814 | 0.220 |
Why?
|
Neoplasm Staging | 12 | 2023 | 11121 | 0.220 |
Why?
|
Chemokine CXCL9 | 1 | 2023 | 135 | 0.220 |
Why?
|
Tracheotomy | 2 | 2018 | 167 | 0.210 |
Why?
|
Thigh | 1 | 2004 | 241 | 0.210 |
Why?
|
Combined Modality Therapy | 9 | 2021 | 8529 | 0.210 |
Why?
|
Cell Differentiation | 1 | 2020 | 11528 | 0.210 |
Why?
|
Mucins | 1 | 2006 | 568 | 0.200 |
Why?
|
Dilatation | 1 | 2023 | 306 | 0.200 |
Why?
|
Middle Aged | 48 | 2024 | 220895 | 0.200 |
Why?
|
Prosthesis Implantation | 3 | 2011 | 592 | 0.190 |
Why?
|
Antibiotic Prophylaxis | 3 | 2016 | 636 | 0.190 |
Why?
|
Osteopontin | 1 | 2023 | 301 | 0.190 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2002 | 318 | 0.190 |
Why?
|
Adenoma | 1 | 2012 | 2160 | 0.190 |
Why?
|
Male | 59 | 2024 | 360804 | 0.180 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2002 | 361 | 0.180 |
Why?
|
Oral Surgical Procedures | 2 | 2021 | 166 | 0.180 |
Why?
|
Trachea | 3 | 2011 | 1089 | 0.170 |
Why?
|
Female | 57 | 2024 | 392644 | 0.170 |
Why?
|
Cell Polarity | 1 | 2023 | 637 | 0.170 |
Why?
|
Blood Transfusion | 2 | 2018 | 1298 | 0.170 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1096 | 0.170 |
Why?
|
Parathyroidectomy | 1 | 2002 | 242 | 0.170 |
Why?
|
Treatment Outcome | 22 | 2023 | 64680 | 0.170 |
Why?
|
Immunohistochemistry | 6 | 2019 | 11076 | 0.170 |
Why?
|
Neck | 1 | 2004 | 734 | 0.170 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2009 | 2825 | 0.170 |
Why?
|
Papillomavirus E7 Proteins | 1 | 2019 | 109 | 0.160 |
Why?
|
Prognosis | 13 | 2023 | 29625 | 0.160 |
Why?
|
Alphapapillomavirus | 1 | 2022 | 218 | 0.160 |
Why?
|
Aged | 39 | 2021 | 169289 | 0.160 |
Why?
|
Chemokines, CXC | 1 | 2020 | 422 | 0.160 |
Why?
|
Carcinoma, Mucoepidermoid | 1 | 2019 | 89 | 0.160 |
Why?
|
Thyroidectomy | 2 | 2015 | 907 | 0.150 |
Why?
|
Head | 1 | 2004 | 924 | 0.150 |
Why?
|
Carcinoma, Acinar Cell | 1 | 2018 | 62 | 0.150 |
Why?
|
Nose Deformities, Acquired | 1 | 2018 | 44 | 0.150 |
Why?
|
Radiotherapy, Adjuvant | 5 | 2020 | 1784 | 0.150 |
Why?
|
Epiglottis | 1 | 2017 | 81 | 0.150 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2019 | 736 | 0.140 |
Why?
|
Neck Dissection | 4 | 2023 | 201 | 0.140 |
Why?
|
Laryngoplasty | 1 | 2017 | 50 | 0.140 |
Why?
|
Neoplasm Metastasis | 5 | 2019 | 4915 | 0.140 |
Why?
|
Scapula | 1 | 2018 | 173 | 0.140 |
Why?
|
Ear Auricle | 2 | 2014 | 31 | 0.140 |
Why?
|
Oropharynx | 3 | 2014 | 138 | 0.140 |
Why?
|
Precancerous Conditions | 1 | 2023 | 980 | 0.130 |
Why?
|
Skin Neoplasms | 4 | 2023 | 5821 | 0.130 |
Why?
|
Esthetics | 2 | 2015 | 330 | 0.130 |
Why?
|
Esophagus | 3 | 2011 | 1033 | 0.130 |
Why?
|
Gene Amplification | 1 | 2020 | 1089 | 0.130 |
Why?
|
Macrophages | 2 | 2023 | 5769 | 0.130 |
Why?
|
Skin Transplantation | 2 | 2018 | 1083 | 0.130 |
Why?
|
Arteries | 2 | 2022 | 1123 | 0.130 |
Why?
|
Adenocarcinoma | 4 | 2009 | 6346 | 0.130 |
Why?
|
Cervicoplasty | 1 | 2015 | 8 | 0.130 |
Why?
|
Estrogen Receptor alpha | 1 | 2019 | 582 | 0.120 |
Why?
|
Speech Intelligibility | 1 | 2015 | 79 | 0.120 |
Why?
|
Intraoperative Complications | 1 | 2002 | 1165 | 0.120 |
Why?
|
Diagnosis, Differential | 8 | 2020 | 12974 | 0.120 |
Why?
|
Urinary Tract Infections | 1 | 2021 | 802 | 0.120 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 559 | 0.120 |
Why?
|
Histoplasma | 1 | 2014 | 39 | 0.120 |
Why?
|
Receptor, Notch1 | 1 | 2017 | 496 | 0.120 |
Why?
|
Clostridium Infections | 1 | 2021 | 558 | 0.120 |
Why?
|
Bacteremia | 1 | 2021 | 979 | 0.120 |
Why?
|
Survival Rate | 9 | 2021 | 12725 | 0.120 |
Why?
|
Histoplasmosis | 1 | 2014 | 63 | 0.120 |
Why?
|
Hypersensitivity | 1 | 2024 | 1171 | 0.120 |
Why?
|
Endoscopy | 2 | 2015 | 1851 | 0.120 |
Why?
|
Tumor Microenvironment | 3 | 2023 | 3877 | 0.120 |
Why?
|
Mouth | 1 | 2017 | 381 | 0.120 |
Why?
|
Skull Fracture, Basilar | 1 | 2013 | 6 | 0.110 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2019 | 611 | 0.110 |
Why?
|
Palatine Tonsil | 1 | 2014 | 193 | 0.110 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1229 | 0.110 |
Why?
|
Exosomes | 1 | 2018 | 424 | 0.110 |
Why?
|
Postoperative Hemorrhage | 2 | 2015 | 415 | 0.110 |
Why?
|
Colonic Neoplasms | 1 | 2006 | 2538 | 0.110 |
Why?
|
Frameshift Mutation | 1 | 2015 | 392 | 0.110 |
Why?
|
Pharyngeal Diseases | 1 | 2014 | 134 | 0.110 |
Why?
|
Databases, Genetic | 1 | 2020 | 1742 | 0.110 |
Why?
|
Length of Stay | 6 | 2021 | 6425 | 0.110 |
Why?
|
Otolaryngology | 1 | 2020 | 693 | 0.110 |
Why?
|
Genes, p53 | 1 | 2015 | 712 | 0.110 |
Why?
|
Pharyngectomy | 3 | 2011 | 44 | 0.110 |
Why?
|
Fractures, Comminuted | 1 | 2013 | 57 | 0.110 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2013 | 87 | 0.110 |
Why?
|
Mutagenesis, Insertional | 1 | 2015 | 656 | 0.110 |
Why?
|
Papillomavirus Vaccines | 1 | 2019 | 496 | 0.110 |
Why?
|
Gastrostomy | 1 | 2015 | 323 | 0.100 |
Why?
|
Lymphocytes | 1 | 2020 | 2612 | 0.100 |
Why?
|
Parotid Diseases | 1 | 2012 | 49 | 0.100 |
Why?
|
Transferrin | 1 | 2013 | 283 | 0.100 |
Why?
|
Chromatin | 2 | 2022 | 2960 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 4 | 2017 | 6484 | 0.100 |
Why?
|
Sphenoid Sinus | 2 | 2009 | 99 | 0.100 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2020 | 4580 | 0.090 |
Why?
|
Olfactory Mucosa | 1 | 2011 | 101 | 0.090 |
Why?
|
Graft Survival | 4 | 2015 | 3819 | 0.090 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 3448 | 0.090 |
Why?
|
Parietal Lobe | 1 | 2015 | 852 | 0.090 |
Why?
|
Chordoma | 1 | 2013 | 347 | 0.090 |
Why?
|
Fibula | 2 | 2024 | 266 | 0.090 |
Why?
|
Adult | 22 | 2021 | 221177 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2020 | 1739 | 0.090 |
Why?
|
Tongue | 2 | 2023 | 403 | 0.090 |
Why?
|
PTEN Phosphohydrolase | 1 | 2015 | 1115 | 0.080 |
Why?
|
Pneumonia | 1 | 2021 | 2143 | 0.080 |
Why?
|
Liposarcoma | 1 | 2012 | 289 | 0.080 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2011 | 156 | 0.080 |
Why?
|
Optic Disk Drusen | 1 | 2009 | 38 | 0.080 |
Why?
|
Risk Assessment | 5 | 2021 | 23995 | 0.080 |
Why?
|
Reoperation | 3 | 2015 | 4303 | 0.080 |
Why?
|
Hemangiosarcoma | 1 | 2011 | 215 | 0.080 |
Why?
|
Quality of Life | 6 | 2024 | 13367 | 0.080 |
Why?
|
Pneumocephalus | 1 | 2008 | 47 | 0.080 |
Why?
|
Forearm | 2 | 2023 | 427 | 0.070 |
Why?
|
Rhinitis | 1 | 2015 | 747 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2022 | 5796 | 0.070 |
Why?
|
Aged, 80 and over | 12 | 2021 | 58976 | 0.070 |
Why?
|
Cell Line, Tumor | 2 | 2022 | 16981 | 0.070 |
Why?
|
Gene Expression Profiling | 2 | 2020 | 9420 | 0.070 |
Why?
|
Ear, External | 1 | 2007 | 165 | 0.070 |
Why?
|
Venous Thrombosis | 1 | 2016 | 1303 | 0.070 |
Why?
|
Ear Canal | 1 | 2007 | 147 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3802 | 0.070 |
Why?
|
Gene Expression | 1 | 2019 | 7581 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3639 | 0.070 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7594 | 0.070 |
Why?
|
Risk Factors | 10 | 2020 | 74206 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2018 | 3065 | 0.070 |
Why?
|
Developing Countries | 2 | 2016 | 2885 | 0.070 |
Why?
|
Keratin-20 | 1 | 2006 | 31 | 0.070 |
Why?
|
Keratin-7 | 1 | 2006 | 55 | 0.070 |
Why?
|
Sinusitis | 1 | 2015 | 991 | 0.070 |
Why?
|
Mucin-2 | 1 | 2006 | 50 | 0.070 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2019 | 3080 | 0.060 |
Why?
|
Carcinoma, Basal Cell | 2 | 2008 | 560 | 0.060 |
Why?
|
Cohort Studies | 6 | 2024 | 41487 | 0.060 |
Why?
|
Hematocrit | 2 | 2018 | 623 | 0.060 |
Why?
|
Ear, Middle | 1 | 2007 | 339 | 0.060 |
Why?
|
Cutaneous Fistula | 2 | 2016 | 79 | 0.060 |
Why?
|
RNA, Messenger | 1 | 2020 | 12795 | 0.060 |
Why?
|
Nose | 2 | 2019 | 521 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2015 | 2917 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 6 | 2013 | 20570 | 0.060 |
Why?
|
Punctures | 3 | 2011 | 366 | 0.060 |
Why?
|
Cheek | 1 | 2004 | 65 | 0.060 |
Why?
|
Follow-Up Studies | 7 | 2015 | 39106 | 0.060 |
Why?
|
Lip Neoplasms | 1 | 2004 | 36 | 0.060 |
Why?
|
Pilot Projects | 3 | 2023 | 8631 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3808 | 0.060 |
Why?
|
Poverty | 1 | 2016 | 2698 | 0.060 |
Why?
|
Transcription Factors | 2 | 2022 | 12128 | 0.060 |
Why?
|
Survival Analysis | 2 | 2014 | 10090 | 0.060 |
Why?
|
Skull | 1 | 2008 | 818 | 0.060 |
Why?
|
Bacteria | 1 | 2014 | 2199 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2015 | 3617 | 0.050 |
Why?
|
Patient Readmission | 1 | 2017 | 3270 | 0.050 |
Why?
|
Postoperative Period | 2 | 2018 | 1813 | 0.050 |
Why?
|
Massachusetts | 4 | 2017 | 8830 | 0.050 |
Why?
|
Lip | 1 | 2004 | 197 | 0.050 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 2 | 2021 | 698 | 0.050 |
Why?
|
Mastoid | 2 | 2014 | 100 | 0.050 |
Why?
|
Melanoma | 1 | 2021 | 5709 | 0.050 |
Why?
|
Xenobiotics | 1 | 2002 | 70 | 0.050 |
Why?
|
Incidence | 6 | 2015 | 21353 | 0.050 |
Why?
|
Salivary Gland Neoplasms | 2 | 2017 | 304 | 0.050 |
Why?
|
Face | 1 | 2008 | 1026 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 2015 | 2332 | 0.050 |
Why?
|
Algorithms | 2 | 2015 | 14031 | 0.050 |
Why?
|
Sensation | 1 | 2023 | 337 | 0.050 |
Why?
|
Weight-Bearing | 1 | 2024 | 532 | 0.050 |
Why?
|
Graft Rejection | 1 | 2014 | 4445 | 0.050 |
Why?
|
Curriculum | 1 | 2014 | 3743 | 0.050 |
Why?
|
Hypocalcemia | 1 | 2002 | 200 | 0.040 |
Why?
|
Young Adult | 7 | 2021 | 59243 | 0.040 |
Why?
|
Intubation, Intratracheal | 1 | 2008 | 1329 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2023 | 22176 | 0.040 |
Why?
|
Radiotherapy Dosage | 3 | 2016 | 2898 | 0.040 |
Why?
|
Radius | 1 | 2023 | 441 | 0.040 |
Why?
|
Time Factors | 3 | 2021 | 39967 | 0.040 |
Why?
|
Deglutition | 1 | 2021 | 208 | 0.040 |
Why?
|
Palate, Soft | 1 | 2019 | 100 | 0.040 |
Why?
|
Biopsy, Needle | 1 | 2004 | 1626 | 0.040 |
Why?
|
Poly I-C | 1 | 2019 | 112 | 0.040 |
Why?
|
Neovascularization, Pathologic | 2 | 2015 | 2645 | 0.040 |
Why?
|
Neoplasm, Residual | 1 | 2024 | 1008 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12059 | 0.040 |
Why?
|
Clinical Competence | 1 | 2014 | 4792 | 0.040 |
Why?
|
Radiotherapy | 2 | 2021 | 1499 | 0.040 |
Why?
|
Calcinosis | 1 | 2007 | 1469 | 0.040 |
Why?
|
Maxilla | 1 | 2021 | 494 | 0.040 |
Why?
|
Catheter-Related Infections | 1 | 2021 | 273 | 0.040 |
Why?
|
Palate | 1 | 2018 | 124 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2015 | 4811 | 0.040 |
Why?
|
Injections, Intramuscular | 1 | 2019 | 554 | 0.040 |
Why?
|
Prolapse | 1 | 2017 | 63 | 0.040 |
Why?
|
Dissection | 1 | 2019 | 298 | 0.040 |
Why?
|
Facial Nerve | 1 | 2020 | 277 | 0.040 |
Why?
|
Mutation | 2 | 2023 | 30052 | 0.040 |
Why?
|
Cicatrix | 1 | 2023 | 798 | 0.040 |
Why?
|
Positive-Pressure Respiration | 1 | 2021 | 639 | 0.040 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2018 | 517 | 0.040 |
Why?
|
Clonal Anergy | 1 | 2017 | 170 | 0.030 |
Why?
|
Perception | 1 | 2023 | 1197 | 0.030 |
Why?
|
Oncogenes | 1 | 2022 | 1222 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12463 | 0.030 |
Why?
|
Sarcoma | 1 | 2008 | 1801 | 0.030 |
Why?
|
Adolescent | 7 | 2017 | 88319 | 0.030 |
Why?
|
Clindamycin | 1 | 2016 | 139 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 4 | 2017 | 36426 | 0.030 |
Why?
|
Facial Paralysis | 1 | 2020 | 346 | 0.030 |
Why?
|
Speech | 1 | 2021 | 554 | 0.030 |
Why?
|
Karnofsky Performance Status | 1 | 2016 | 166 | 0.030 |
Why?
|
Tomography, Optical Coherence | 1 | 2009 | 2917 | 0.030 |
Why?
|
Lymphatic Irradiation | 1 | 2016 | 115 | 0.030 |
Why?
|
Prospective Studies | 4 | 2021 | 54425 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2019 | 1351 | 0.030 |
Why?
|
Vision Disorders | 2 | 2015 | 1088 | 0.030 |
Why?
|
Apoptosis | 2 | 2020 | 9486 | 0.030 |
Why?
|
Pakistan | 1 | 2016 | 292 | 0.030 |
Why?
|
Cadaver | 1 | 2019 | 1358 | 0.030 |
Why?
|
Biopsy, Fine-Needle | 1 | 2020 | 1118 | 0.030 |
Why?
|
Africa, Eastern | 1 | 2014 | 76 | 0.030 |
Why?
|
DNA, Viral | 1 | 2022 | 2202 | 0.030 |
Why?
|
Actinomycosis | 1 | 2014 | 19 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2020 | 0.030 |
Why?
|
Endocrinology | 1 | 2020 | 442 | 0.030 |
Why?
|
Relative Biological Effectiveness | 1 | 2016 | 312 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2015 | 9031 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 22170 | 0.030 |
Why?
|
Kinetics | 1 | 2022 | 6374 | 0.030 |
Why?
|
Pseudomonas Infections | 1 | 2018 | 622 | 0.030 |
Why?
|
Aphasia | 1 | 2015 | 192 | 0.030 |
Why?
|
Bangladesh | 1 | 2016 | 736 | 0.030 |
Why?
|
Cleft Palate | 1 | 2019 | 589 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2019 | 1251 | 0.030 |
Why?
|
Ligands | 1 | 2020 | 3272 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2019 | 1560 | 0.030 |
Why?
|
Clavicle | 1 | 2015 | 224 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2002 | 2303 | 0.030 |
Why?
|
Up-Regulation | 1 | 2002 | 4124 | 0.030 |
Why?
|
Pharyngitis | 1 | 2014 | 219 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2019 | 18965 | 0.030 |
Why?
|
Protons | 2 | 2009 | 1116 | 0.030 |
Why?
|
Sulfonamides | 1 | 2002 | 1978 | 0.030 |
Why?
|
Device Removal | 1 | 2017 | 630 | 0.030 |
Why?
|
Disease Progression | 1 | 2009 | 13506 | 0.030 |
Why?
|
Cancer Vaccines | 1 | 2019 | 1051 | 0.020 |
Why?
|
Bronchoscopy | 1 | 2017 | 909 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2017 | 2510 | 0.020 |
Why?
|
Child | 6 | 2017 | 80153 | 0.020 |
Why?
|
Brain Edema | 1 | 2015 | 604 | 0.020 |
Why?
|
Craniotomy | 1 | 2015 | 741 | 0.020 |
Why?
|
Osteoradionecrosis | 1 | 2011 | 51 | 0.020 |
Why?
|
Health Services | 1 | 2016 | 752 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2019 | 3162 | 0.020 |
Why?
|
Forecasting | 1 | 2020 | 2928 | 0.020 |
Why?
|
Bone Transplantation | 1 | 2015 | 929 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2017 | 2645 | 0.020 |
Why?
|
Cranial Fossa, Anterior | 1 | 2009 | 13 | 0.020 |
Why?
|
Osteotomy | 1 | 2015 | 837 | 0.020 |
Why?
|
Chronic Disease | 2 | 2015 | 9318 | 0.020 |
Why?
|
Texas | 1 | 2011 | 404 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2018 | 2135 | 0.020 |
Why?
|
Biopsy | 2 | 2014 | 6766 | 0.020 |
Why?
|
Education, Medical, Continuing | 1 | 2014 | 823 | 0.020 |
Why?
|
India | 1 | 2016 | 2348 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2017 | 4111 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2016 | 2426 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3849 | 0.020 |
Why?
|
Risk | 1 | 2020 | 9610 | 0.020 |
Why?
|
SEER Program | 1 | 2013 | 1450 | 0.020 |
Why?
|
Radiation Injuries | 1 | 2016 | 1189 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2019 | 5486 | 0.020 |
Why?
|
Patient Discharge | 1 | 2021 | 3443 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2016 | 1403 | 0.020 |
Why?
|
Cancer Care Facilities | 1 | 2011 | 422 | 0.020 |
Why?
|
Staphylococcal Infections | 1 | 2016 | 1408 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2014 | 1505 | 0.020 |
Why?
|
Paranasal Sinuses | 1 | 2009 | 265 | 0.020 |
Why?
|
Vaccination | 1 | 2019 | 3384 | 0.020 |
Why?
|
Visual Field Tests | 1 | 2009 | 411 | 0.020 |
Why?
|
Nose Diseases | 1 | 2007 | 79 | 0.020 |
Why?
|
Neutrons | 1 | 2006 | 77 | 0.020 |
Why?
|
Mandible | 1 | 2011 | 753 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2017 | 2449 | 0.020 |
Why?
|
Cranial Fossa, Posterior | 1 | 2006 | 135 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2020 | 3530 | 0.020 |
Why?
|
Fibroma | 1 | 2007 | 190 | 0.020 |
Why?
|
Cytoskeletal Proteins | 1 | 2011 | 1342 | 0.020 |
Why?
|
Cavernous Sinus | 1 | 2006 | 123 | 0.020 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2009 | 339 | 0.020 |
Why?
|
Bone Neoplasms | 1 | 2017 | 2529 | 0.020 |
Why?
|
Data Collection | 1 | 2014 | 3322 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2017 | 3466 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2169 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2015 | 2220 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2017 | 4369 | 0.020 |
Why?
|
Enteral Nutrition | 1 | 2011 | 794 | 0.010 |
Why?
|
Mass Screening | 1 | 2020 | 5428 | 0.010 |
Why?
|
Mice | 2 | 2023 | 81525 | 0.010 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2006 | 290 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 2009 | 1204 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13255 | 0.010 |
Why?
|
Glycoproteins | 1 | 2011 | 2203 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2016 | 26125 | 0.010 |
Why?
|
Neurons | 1 | 2023 | 9463 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8547 | 0.010 |
Why?
|
Carbon | 1 | 2006 | 666 | 0.010 |
Why?
|
Inflammation | 1 | 2002 | 10773 | 0.010 |
Why?
|
Visual Fields | 1 | 2009 | 1062 | 0.010 |
Why?
|
Prosthesis Design | 1 | 2009 | 2115 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7827 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2005 | 13639 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15266 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 22169 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2011 | 5247 | 0.010 |
Why?
|
Phenotype | 1 | 2017 | 16591 | 0.010 |
Why?
|
Smoking | 1 | 2016 | 9053 | 0.010 |
Why?
|
Animals | 2 | 2023 | 168459 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15732 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7407 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23445 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 17904 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2009 | 4063 | 0.010 |
Why?
|
United States | 2 | 2013 | 72334 | 0.010 |
Why?
|
Infant | 1 | 2015 | 36192 | 0.010 |
Why?
|
Child, Preschool | 1 | 2015 | 42230 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2009 | 9000 | 0.010 |
Why?
|